MISSION VIEJO, Calif., Sept. 20, 2016 -- The Ensign Group, Inc. (NASDAQ:ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care, assisted living and urgent care companies, today announced that it has declared a quarterly cash dividend of $0.04 per share of Ensign common stock, payable on or before October 31, 2016, to shareholders of record as of September 30, 2016. Ensign has been a dividend-paying company since 2002.
About Ensign ™
The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and assisted living services, physical, occupational and speech therapies, home health and hospice services, urgent care services and other rehabilitative and healthcare services at 208 healthcare facilities, seventeen hospice agencies, seventeen home health agencies, three home care businesses and fourteen urgent care clinics in California, Arizona, Texas, Washington, Utah, Idaho, Colorado, Nevada, Iowa, Nebraska, Oregon, Wisconsin, Kansas and South Carolina. More information about Ensign is available at http://www.ensigngroup.net.
The Ensign Group, Inc., (949) 487-9500, [email protected]


Applied Materials Forecasts Strong Q3 Revenue as AI Chip Demand Accelerates
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Honda Shares Jump as Automaker Forecasts Profit Recovery Despite Historic Loss
Samsung, Union Edge Closer to Deal as Strike Threat Looms
Amazon Faces Class-Action Lawsuit Over Trump Tariff Price Hikes
Thyssenkrupp to Shut Down Indiana Automotive Plant by March 2026
US-China Trade Talks Sideline Chip Export Controls as Nvidia China Sales Draw Attention
Google, Blackstone Launch $5B AI Cloud Venture to Challenge Nvidia and CoreWeave
YouTube and Snap Settle School District Mental Health Lawsuit Ahead of Major Social Media Trial
Anthropic to Brief Financial Stability Board on AI-Driven Cyber Risks
Standard Chartered Appoints Manus Costello as New CFO Amid Leadership Reshuffle
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness
CXMT Forecasts Record Revenue Growth as Global DRAM Prices Surge 



